UNSPSC 51294405: Delfaprazine

This classification denotes an antidepressant agent with the molecular formula C18H22N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06YTS68E0H, chemically known as 1-(alpha,alpha-phenyl-2,5-xylyl)pi-perazine. but generally known as delfaprazine, which bears US NIH Compound Identifier 205972. European Medicines Agency schedules Delfaprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06953MIG.

UNSPSC 51294405 Delfaprazine is a Commodity code that captures pharmaceutical products procured by state and local health and safety agencies. The code shows minimal recent activity aligned to its nominal scope; the single recent opportunity in the dataset is Seminole County, Florida's IFB60459723LAS, which solicits Naloxone and Safe Drug Deactivation Systems rather than delfaprazine itself. This mismatch suggests either a tagging error in the procurement system or a broader interpretation of the code to encompass opioid-antagonist and drug-management pharmaceuticals. The actual work being procured under this tag involves emergency-response pharmaceutical supplies and drug-disposal systems for community health initiatives, with quarterly delivery commitments and fixed-fee pricing.

Seminole County, Florida represents the only visible recent issuer under this code in the current dataset. The IFB posted June 30, 2026, sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, suggesting a potential data-alignment issue in the source records. Contractors must cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and meet drug-free workplace certification standards. The contract spans an initial two-year term with a one-year renewal option and includes potential FEMA funding with associated federal compliance obligations. The geographic spread is limited to Florida based on available records, and the issuing body is a single county health procurement function rather than a statewide or multi-jurisdictional effort.